COVID-19 Pandemic-Related Impacts on Newborn Screening Public Health Surveillance

Abstract

by Sikha Singh,Michele Caggana,Carol Johnson,Rachel Lee,Guisou Zarbalian,Amy Gaviglio,Alisha Keehn,Mia Morrison,Scott J. Becker andJelili Ojodu
Int. J. Neonatal Screen. 2022, 8(2), 28; https://doi.org/10.3390/ijns8020028 - 15 Apr 2022
Cited by 5 | Viewed by 3980
Abstract
Newborn screening (NBS) is an essential public health service that performs screening to identify those newborns at increased risk for a panel of disorders, most of which are genetic. The goal of screening is to link those newborns at the highest risk to timely intervention and potentially life-saving treatment. The global COVID-19 pandemic led to disruptions within the United States public health system, revealing implications for the continuity of newborn screening laboratories and follow-up operations. The impacts of COVID-19 across different states at various time points meant that NBS programs impacted by the pandemic later could benefit from the immediate experiences of the earlier impacted programs. This article will review the collection, analysis, and dissemination of information during the COVID-19 pandemic facilitated by a national, centralized technical assistance and resource center for NBS programs. Full article
(This article belongs to the Special Issue The COVID-19 Pandemic: The Impact on Newborn Screening Research, Clinical Care and Public Health)
9 pages, 629 KiB
Open AccessArticle